{"id":914291,"date":"2025-11-28T08:41:27","date_gmt":"2025-11-28T13:41:27","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/cuprina-holdings-cayman-limited-announces-receipt-of-nasdaq-notification-letter-regarding-minimum-bid-price-deficiency\/"},"modified":"2025-11-28T08:41:27","modified_gmt":"2025-11-28T13:41:27","slug":"cuprina-holdings-cayman-limited-announces-receipt-of-nasdaq-notification-letter-regarding-minimum-bid-price-deficiency","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/cuprina-holdings-cayman-limited-announces-receipt-of-nasdaq-notification-letter-regarding-minimum-bid-price-deficiency\/","title":{"rendered":"Cuprina Holdings (Cayman) Limited Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">SINGAPORE, Nov.  28, 2025  (GLOBE NEWSWIRE) &#8212; <b>Cuprina Holdings (Cayman) Limited<\/b> (<b>Nasdaq: CUPR<\/b>) (\u201c<b>Cuprina<\/b>\u201d or \u201c<b>the Company<\/b>\u201d), a biomedical company developing and marketing products for the chronic wounds, infertility, and cosmeceuticals sectors, today announced it has received a letter of noncompliance from The Nasdaq Stock Market LLC\u00a0(&#8220;Nasdaq&#8221;), dated\u00a0November 26, 2025, notifying the Company that based on Cuprina\u2019s closing bid price for the last 30 consecutive business days, the Company no longer meets the continued listing requirement of Nasdaq, under Nasdaq Listing Rules 5550(a)(2), to maintain a minimum bid price of\u00a0$1\u00a0per share.<\/p>\n<p align=\"justify\">However, pursuant to Nasdaq Listing Rule 5810(c)(3)(A), the Company has a compliance period of 180 calendar days in which to regain compliance. If at any time during this 180-day period the closing bid price of the Company\u2019s security is at least $1 for a minimum of ten consecutive business days, Nasdaq will provide Cuprina with written confirmation of compliance and this matter will be closed. <\/p>\n<p align=\"justify\">In the event the Company does not regain compliance, Cuprina may be eligible for additional time. To qualify, the Company will be required to meet the continued listing requirement for market value of publicly held shares and all other initial listing standards for The Nasdaq Capital Market, with the exception of the bid price requirement, and will need to provide written notice of its intention to cure the deficiency during the second compliance period, by effecting a reverse stock split, if necessary. If the Cuprina meets these requirements, Nasdaq will inform the Company that it has been granted an additional 180 calendar days. However, if it appears to Nasdaq that the Company will not be able to cure the deficiency, or if the Company is otherwise not eligible, Nasdaq will provide notice that its securities will be subject to delisting.<\/p>\n<p align=\"justify\">The Nasdaq notification letter does not result in the immediate delisting of the Company&#8217;s ordinary shares, and the shares will continue to trade uninterrupted under the symbol &#8220;CUPR.&#8221;\u00a0<\/p>\n<p align=\"justify\">Cuprina is currently evaluating options to regain compliance and intends to timely regain compliance with Nasdaq\u2019s continued listing requirement. Although Cuprina will use all reasonable efforts to achieve compliance with Rule 5550(a)(2), there can be no assurance that the Company will be able to regain compliance with that rule or will otherwise be in compliance with other Nasdaq continued listing requirement.<\/p>\n<p>\n        <b>About Cuprina Holdings (Cayman) Limited<\/b>\n      <\/p>\n<p align=\"justify\">We are a Singapore-based biomedical and biotechnology company that is dedicated to the development and commercialization of innovative products for the management of chronic wounds, as well as operating in the health and beauty sectors. Our expertise in biomedical research allows us to identify and utilize materials derived from natural sources to develop wound care products in the form of medical devices which meet international standards. For more information, please visit https:\/\/ <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=vKXdS1H9w8sjJfoGQSAAkQhT8foOj_ENVlzaT1bzX_pvmP4BHou-p7LGsZ1-ixamiMv-33LtnYnET08V92ihaA==\" rel=\"nofollow\" target=\"_blank\">www.cuprina.com<\/a>.\u00a0 <\/p>\n<p>\n        <b>FORWARD-LOOKING STATEMENTS<\/b>\n      <\/p>\n<p align=\"justify\">Certain statements contained in this press release about future expectations, plans and prospects, as well as any other statements regarding matters that are not historical facts, may constitute \u201cforward-looking statements\u201d within the meaning of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements relating to the expected trading commencement and closing dates. The words \u201canticipate,\u201d \u201cbelieve,\u201d \u201ccontinue,\u201d \u201ccould,\u201d \u201cestimate,\u201d \u201cexpect,\u201d \u201cintend,\u201d \u201cmay,\u201d \u201cplan,\u201d \u201cpotential,\u201d \u201cpredict,\u201d \u201cproject,\u201d \u201cshould,\u201d \u201ctarget,\u201d \u201cwill,\u201d \u201cwould\u201d and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including: the uncertainties related to market conditions and the completion of the public offering on the anticipated terms or at all, and other factors discussed in the \u201cRisk Factors\u201d section of the preliminary prospectus filed with the SEC. For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Any forward-looking statements contained in this press release speak only as of the date hereof, and Cuprina Holdings (Cayman) Limited specifically disclaims any obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by law.<\/p>\n<p>\n        <b>Cuprina Holdings (Cayman) Limited Investor Contact<\/b><br \/>\n        <br \/>Investor Relations<br \/>c\/o Blk 1090 Lower Delta Road #06-08<br \/>Singapore 169201<br \/>+65 8512 7275<br \/>Email: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=VhPlflSbvR27EAVWhmTmXCf-aAu_AY_9ao4Geq5oO4aSIQ6uaNhma59jfdPYOl1em5JOX-N8JKSTmPpo48GAhLtanWZACKI-RJQqkTD3iOc=\" rel=\"nofollow\" target=\"_blank\">ir@cuprina.com.sg<\/a><\/p>\n<p>\n        <b>Investor Relations Inquiries:<\/b><br \/>\n        <br \/>Skyline Corporate Communications Group, LLC<br \/>Scott Powell, President<br \/>1177 Avenue of the Americas, 5<sup>th<\/sup> Floor<br \/>New York, New York 10036<br \/>Office: (646) 893-5835<br \/>Email: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Mdfan1d0XIBL2_UvFgPWIr9vaSSvi9tnb5SrCPUPOZncSVfu2iadacESSFEHeV3z4eC96MhdFkIZtbIhtSfTIq21rofatXIrDThq4Q3Gdsc=\" rel=\"nofollow\" target=\"_blank\">info@skylineccg.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU5MzU2MiM3Mjk2NDEyIzUwMDEyODY3Mg==\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/MjRlNTM3YzctZTJhOC00NzYwLWI5ODktMDZiZmY0ODNiNDA2LTUwMDEyODY3Mi0yMDI1LTExLTI4LWVu\/tiny\/Cuprina-Holdings-Cayman-LTD.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SINGAPORE, Nov. 28, 2025 (GLOBE NEWSWIRE) &#8212; Cuprina Holdings (Cayman) Limited (Nasdaq: CUPR) (\u201cCuprina\u201d or \u201cthe Company\u201d), a biomedical company developing and marketing products for the chronic wounds, infertility, and cosmeceuticals sectors, today announced it has received a letter of noncompliance from The Nasdaq Stock Market LLC\u00a0(&#8220;Nasdaq&#8221;), dated\u00a0November 26, 2025, notifying the Company that based on Cuprina\u2019s closing bid price for the last 30 consecutive business days, the Company no longer meets the continued listing requirement of Nasdaq, under Nasdaq Listing Rules 5550(a)(2), to maintain a minimum bid price of\u00a0$1\u00a0per share. However, pursuant to Nasdaq Listing Rule 5810(c)(3)(A), the Company has a compliance period of 180 calendar days in which to regain compliance. If at any time during this 180-day &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/cuprina-holdings-cayman-limited-announces-receipt-of-nasdaq-notification-letter-regarding-minimum-bid-price-deficiency\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Cuprina Holdings (Cayman) Limited Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-914291","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Cuprina Holdings (Cayman) Limited Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/cuprina-holdings-cayman-limited-announces-receipt-of-nasdaq-notification-letter-regarding-minimum-bid-price-deficiency\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cuprina Holdings (Cayman) Limited Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SINGAPORE, Nov. 28, 2025 (GLOBE NEWSWIRE) &#8212; Cuprina Holdings (Cayman) Limited (Nasdaq: CUPR) (\u201cCuprina\u201d or \u201cthe Company\u201d), a biomedical company developing and marketing products for the chronic wounds, infertility, and cosmeceuticals sectors, today announced it has received a letter of noncompliance from The Nasdaq Stock Market LLC\u00a0(&#8220;Nasdaq&#8221;), dated\u00a0November 26, 2025, notifying the Company that based on Cuprina\u2019s closing bid price for the last 30 consecutive business days, the Company no longer meets the continued listing requirement of Nasdaq, under Nasdaq Listing Rules 5550(a)(2), to maintain a minimum bid price of\u00a0$1\u00a0per share. However, pursuant to Nasdaq Listing Rule 5810(c)(3)(A), the Company has a compliance period of 180 calendar days in which to regain compliance. If at any time during this 180-day &hellip; Continue reading &quot;Cuprina Holdings (Cayman) Limited Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/cuprina-holdings-cayman-limited-announces-receipt-of-nasdaq-notification-letter-regarding-minimum-bid-price-deficiency\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-28T13:41:27+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU5MzU2MiM3Mjk2NDEyIzUwMDEyODY3Mg==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cuprina-holdings-cayman-limited-announces-receipt-of-nasdaq-notification-letter-regarding-minimum-bid-price-deficiency\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cuprina-holdings-cayman-limited-announces-receipt-of-nasdaq-notification-letter-regarding-minimum-bid-price-deficiency\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Cuprina Holdings (Cayman) Limited Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency\",\"datePublished\":\"2025-11-28T13:41:27+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cuprina-holdings-cayman-limited-announces-receipt-of-nasdaq-notification-letter-regarding-minimum-bid-price-deficiency\\\/\"},\"wordCount\":744,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cuprina-holdings-cayman-limited-announces-receipt-of-nasdaq-notification-letter-regarding-minimum-bid-price-deficiency\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU5MzU2MiM3Mjk2NDEyIzUwMDEyODY3Mg==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cuprina-holdings-cayman-limited-announces-receipt-of-nasdaq-notification-letter-regarding-minimum-bid-price-deficiency\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cuprina-holdings-cayman-limited-announces-receipt-of-nasdaq-notification-letter-regarding-minimum-bid-price-deficiency\\\/\",\"name\":\"Cuprina Holdings (Cayman) Limited Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cuprina-holdings-cayman-limited-announces-receipt-of-nasdaq-notification-letter-regarding-minimum-bid-price-deficiency\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cuprina-holdings-cayman-limited-announces-receipt-of-nasdaq-notification-letter-regarding-minimum-bid-price-deficiency\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU5MzU2MiM3Mjk2NDEyIzUwMDEyODY3Mg==\",\"datePublished\":\"2025-11-28T13:41:27+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cuprina-holdings-cayman-limited-announces-receipt-of-nasdaq-notification-letter-regarding-minimum-bid-price-deficiency\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cuprina-holdings-cayman-limited-announces-receipt-of-nasdaq-notification-letter-regarding-minimum-bid-price-deficiency\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cuprina-holdings-cayman-limited-announces-receipt-of-nasdaq-notification-letter-regarding-minimum-bid-price-deficiency\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU5MzU2MiM3Mjk2NDEyIzUwMDEyODY3Mg==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU5MzU2MiM3Mjk2NDEyIzUwMDEyODY3Mg==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cuprina-holdings-cayman-limited-announces-receipt-of-nasdaq-notification-letter-regarding-minimum-bid-price-deficiency\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cuprina Holdings (Cayman) Limited Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cuprina Holdings (Cayman) Limited Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/cuprina-holdings-cayman-limited-announces-receipt-of-nasdaq-notification-letter-regarding-minimum-bid-price-deficiency\/","og_locale":"en_US","og_type":"article","og_title":"Cuprina Holdings (Cayman) Limited Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency - Market Newsdesk","og_description":"SINGAPORE, Nov. 28, 2025 (GLOBE NEWSWIRE) &#8212; Cuprina Holdings (Cayman) Limited (Nasdaq: CUPR) (\u201cCuprina\u201d or \u201cthe Company\u201d), a biomedical company developing and marketing products for the chronic wounds, infertility, and cosmeceuticals sectors, today announced it has received a letter of noncompliance from The Nasdaq Stock Market LLC\u00a0(&#8220;Nasdaq&#8221;), dated\u00a0November 26, 2025, notifying the Company that based on Cuprina\u2019s closing bid price for the last 30 consecutive business days, the Company no longer meets the continued listing requirement of Nasdaq, under Nasdaq Listing Rules 5550(a)(2), to maintain a minimum bid price of\u00a0$1\u00a0per share. However, pursuant to Nasdaq Listing Rule 5810(c)(3)(A), the Company has a compliance period of 180 calendar days in which to regain compliance. If at any time during this 180-day &hellip; Continue reading \"Cuprina Holdings (Cayman) Limited Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/cuprina-holdings-cayman-limited-announces-receipt-of-nasdaq-notification-letter-regarding-minimum-bid-price-deficiency\/","og_site_name":"Market Newsdesk","article_published_time":"2025-11-28T13:41:27+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU5MzU2MiM3Mjk2NDEyIzUwMDEyODY3Mg==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cuprina-holdings-cayman-limited-announces-receipt-of-nasdaq-notification-letter-regarding-minimum-bid-price-deficiency\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cuprina-holdings-cayman-limited-announces-receipt-of-nasdaq-notification-letter-regarding-minimum-bid-price-deficiency\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Cuprina Holdings (Cayman) Limited Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency","datePublished":"2025-11-28T13:41:27+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cuprina-holdings-cayman-limited-announces-receipt-of-nasdaq-notification-letter-regarding-minimum-bid-price-deficiency\/"},"wordCount":744,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cuprina-holdings-cayman-limited-announces-receipt-of-nasdaq-notification-letter-regarding-minimum-bid-price-deficiency\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU5MzU2MiM3Mjk2NDEyIzUwMDEyODY3Mg==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cuprina-holdings-cayman-limited-announces-receipt-of-nasdaq-notification-letter-regarding-minimum-bid-price-deficiency\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/cuprina-holdings-cayman-limited-announces-receipt-of-nasdaq-notification-letter-regarding-minimum-bid-price-deficiency\/","name":"Cuprina Holdings (Cayman) Limited Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cuprina-holdings-cayman-limited-announces-receipt-of-nasdaq-notification-letter-regarding-minimum-bid-price-deficiency\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cuprina-holdings-cayman-limited-announces-receipt-of-nasdaq-notification-letter-regarding-minimum-bid-price-deficiency\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU5MzU2MiM3Mjk2NDEyIzUwMDEyODY3Mg==","datePublished":"2025-11-28T13:41:27+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cuprina-holdings-cayman-limited-announces-receipt-of-nasdaq-notification-letter-regarding-minimum-bid-price-deficiency\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/cuprina-holdings-cayman-limited-announces-receipt-of-nasdaq-notification-letter-regarding-minimum-bid-price-deficiency\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cuprina-holdings-cayman-limited-announces-receipt-of-nasdaq-notification-letter-regarding-minimum-bid-price-deficiency\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU5MzU2MiM3Mjk2NDEyIzUwMDEyODY3Mg==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU5MzU2MiM3Mjk2NDEyIzUwMDEyODY3Mg=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cuprina-holdings-cayman-limited-announces-receipt-of-nasdaq-notification-letter-regarding-minimum-bid-price-deficiency\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Cuprina Holdings (Cayman) Limited Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/914291","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=914291"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/914291\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=914291"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=914291"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=914291"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}